GlassScriptPhysician profile
Arthur J Rosner
NPI 1790781573
$11,962.03
in general payments reported to CMS, 2019-2025
24 companies · $877 in 2025
The $877 reported for 2025 was more than what 77% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,904 · 2020: $637 · 2021: $1,587 · 2022: $2,781 · 2023: $865 · 2024: $2,311 · 2025: $877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,830 · Travel and Lodging: $1,189 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,830.31 |
| Travel and Lodging | $1,188.72 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $2,664.46 | 2019-2022 | |
| Acelrx Pharmaceuticals, INC. | $2,263.95 | 2022 | |
| Stryker Corporation | $2,158.30 | 2019-2024 | Scopis Ent, Clarifix Cryotherapy Device, Latera |
| Aerin Medical INC. | $916.97 | 2019-2023 | |
| Harmony Biosciences LLC | $781.19 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $670.25 | 2019-2025 | Xywav |
| Optinose US, INC. | $456.21 | 2019-2024 | |
| Genzyme Corporation | $444.40 | 2021-2025 | |
| Axsome Therapeutics, INC. | $416.16 | 2023-2025 | Sunosi |
| Regeneron Healthcare Solutions, INC. | $401.17 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $227.30 | 2021-2024 | Nucala |
| Acclarent, INC | $152.35 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $145.96 | 2025 | Tezspire |
| Amgen INC. | $34.00 | 2025 | |
| Neurent Medical Limited | $33.34 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $30.35 | 2024 | Inspire |
| Fortovia Therapeutics, INC. | $25.46 | 2019-2020 | |
| Resmed Corp | $24.60 | 2019 | |
| Hologic Sales and Service, LLC | $23.93 | 2023 | Coolseal Generator |
| Davol INC. | $22.61 | 2020 | |
| Avadel Cns Pharmaceuticals, LLC | $20.05 | 2025 | Lumryz |
| Paratek Pharmaceuticals, INC. | $18.01 | 2025 | Xhance |
| Merck Sharp & Dohme LLC | $17.88 | 2023 | |
| Sanofi-Aventis U.S. LLC | $13.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Rosner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.